
TOKYO -- VLP Therapeutics Japan has begun a clinical trial of a new coronavirus vaccine that would require a far smaller dosage than those of Pfizer and Moderna, and could dramatically shorten production time, the company said Monday.
Shot requires smaller dose, allows faster production, CEO says
TOKYO -- VLP Therapeutics Japan has begun a clinical trial of a new coronavirus vaccine that would require a far smaller dosage than those of Pfizer and Moderna, and could dramatically shorten production time, the company said Monday.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.